Natalya A. Ilyenkova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Natalya A. Ilyenkova has a total of 279 co-authors. Here are the top co-authors by number of shared publications:
- Elena Ivanovna Kondratieva
Research Centre for Medical Genetics, Moscow 115522, Russia
7 shared publications - Anna Yu. Voronkova
Research Centre for Medical Genetics
5 shared publications - Elena K. Zhekaite
Clinical Research Institute for Childhood Diseases, Moscow Region Ministry of Health; Research Centre for Medical Genetics
5 shared publications - Ludmila V. Stepanova
Voyno-Yasenetsky Krasnoyarsk State Medical University
5 shared publications - Diana Fikretovna Sergienko
Astrakhan State Medical University
4 shared publications - Leonid Yakovlevich Klimov
Stavropol State Medical University
4 shared publications
Latest Publications
- Open Access
- 17 November 2025
- Published by Consilium Medicum in Consilium Medicum
- Vol. 27 (9) , 517-520
Asthmatic status of a child with severe bronchial asthma. Case report
The article describes a clinical case of asthmatic status in a child with severe bronchial asthma, which clearly demonstrates the importance of organizing rational medical care for this group of patients at the stage of a territorial polyclinic, where timely measures should be taken to assess the effectiveness of current anti-inflammatory therapy, review its scope, and especially paperwork to provide patients with vital medicines in the preferential drug treatment system provision of citizens. Personalized phenotype determination and therapy selection are needed for patients who do not achieve control on medium and high doses of inhaled glucocorticosteroids in combination with long-acting β2-agonists and who have a history of severe exacerbations. It is important to observe the continuity of medical care for such patients at the inpatient and outpatient stages.
- 17 November 2025
- Published by Consilium Medicum in Consilium Medicum
- Vol. 27 (9) , 517-520
Open AccessAsthmatic status of a child with severe bronchial asthma. Case report
The article describes a clinical case of asthmatic status in a child with severe bronchial asthma, which clearly demonstrates the importance of organizing rational medical care for this group of patients at the stage of a territorial polyclinic, where timely measures should be taken to assess the effectiveness of current anti-inflammatory therapy, review its scope, and especially paperwork to provide patients with vital medicines in the preferential drug treatment system provision of citizens. Personalized phenotype determination and therapy selection are needed for patients who do not achieve control on medium and high doses of inhaled glucocorticosteroids in combination with long-acting β2-agonists and who have a history of severe exacerbations. It is important to observe the continuity of medical care for such patients at the inpatient and outpatient stages.
- Open Access
- 18 April 2025
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 35 (2) , 213-220
Using elexacaftor/tezacaftor/ivacaftor + ivacaftor in preschool children with cystic fibrosis
Опыт применения препарата элексакафтор / тезакафтор / ивакафтор + ивакафтор у детей с муковисцидозом дошкольного возраста
- 18 April 2025
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 35 (2) , 213-220
Open AccessUsing elexacaftor/tezacaftor/ivacaftor + ivacaftor in preschool children with cystic fibrosis
Опыт применения препарата элексакафтор / тезакафтор / ивакафтор + ивакафтор у детей с муковисцидозом дошкольного возраста
- Open Access
- 4 April 2025
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- Vol. 1 (1) , 74-79
Acute respiratory viral infection in children: an open dialogue live. Resolution of the International Expert Council December 8, 2024 Moscow
On December 8, 2024, the International Council of Experts was held in Moscow to discuss methods of prevention and comprehensive therapy of respiratory infectious diseases in children, including those with chronic diseases. The experts presented reports on several topical issues: the current epidemic situation of acute respiratory viral infections (ARVI) and influenza, the problem of prevention and treatment of influenza and ARVI in children, including those with allergic conditions, chronic hepatitis, and the peculiarities of the effect of respiratory viruses on immunity in children. The paper focused on the evidence base, efficacy, and safety of Cytovir-3, a drug for the prevention, etiotropic, and immunostimulating therapy of influenza and ARVI.
- 4 April 2025
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- Vol. 1 (1) , 74-79
Open AccessAcute respiratory viral infection in children: an open dialogue live. Resolution of the International Expert Council December 8, 2024 Moscow
On December 8, 2024, the International Council of Experts was held in Moscow to discuss methods of prevention and comprehensive therapy of respiratory infectious diseases in children, including those with chronic diseases. The experts presented reports on several topical issues: the current epidemic situation of acute respiratory viral infections (ARVI) and influenza, the problem of prevention and treatment of influenza and ARVI in children, including those with allergic conditions, chronic hepatitis, and the peculiarities of the effect of respiratory viruses on immunity in children. The paper focused on the evidence base, efficacy, and safety of Cytovir-3, a drug for the prevention, etiotropic, and immunostimulating therapy of influenza and ARVI.
- 28 February 2025
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 104 (1)
"Recent developments in the nutrition of children with cystic fibrosis," Resolution by the Expert Council dated December 12, 2024, Moscow, Russia
T.E. Borovik, O.I. Simonova, S.V. Voronin, T.V. Bushuyeva, Ina Sokolov, A.A. Pashkevich, A.E. Lavrova, N.A. Ilyenkova, D.F. Sergiyenko, A.A. Agafonova, N.Yu. Filina, I.P. Karimova. "Recent developments in the nutrition of children with cystic fibrosis," Resolution by the Expert Council dated December 12, 2024, Moscow, Russia. Pediatria n.a. G.N. Speransky. 2025; 104 (1): 151-154. DOI: 10.24110/0031-403X-2025-104-1-151-154.
- 28 February 2025
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 104 (1)
"Recent developments in the nutrition of children with cystic fibrosis," Resolution by the Expert Council dated December 12, 2024, Moscow, Russia
T.E. Borovik, O.I. Simonova, S.V. Voronin, T.V. Bushuyeva, Ina Sokolov, A.A. Pashkevich, A.E. Lavrova, N.A. Ilyenkova, D.F. Sergiyenko, A.A. Agafonova, N.Yu. Filina, I.P. Karimova. "Recent developments in the nutrition of children with cystic fibrosis," Resolution by the Expert Council dated December 12, 2024, Moscow, Russia. Pediatria n.a. G.N. Speransky. 2025; 104 (1): 151-154. DOI: 10.24110/0031-403X-2025-104-1-151-154.
- 1 January 2025
- Published by Dynasty Publishing House in Voprosy praktičeskoj pediatrii
- Vol. 20 (2)
Surfactant proteins A and D in the diagnosis of community-acquired pneumonia in children
Community-acquired pneumonia (CAP) remains one of the leading causes of children’s hospitalization, emphasizing the need to find reliable diagnostic biomarkers. Surfactant proteins SP-A and SP-D, which are important components of lung secretion, are considered as potential markers of inflammation in CAP, but their diagnostic significance in pediatric practice remains understudied. Objective. To evaluate the diagnostic value of surfactant proteins A (SP-A) and D (SP-D) in blood for the diagnosis of CAP in children. Patients and methods. This case-control observational study included 88 children. The control group comprised of 29 children without bronchopulmonary pathology, the study group – 59 children with CAP. Clinical parameters (respiratory rate (RR), heart rate (HR), saturation (SpO2), length of hospital stay, levels of surfactant proteins (SP-A and SP-D), inflammatory biomarkers (white blood cell count, neutrophil count, neutrophil-to-lymphocyte ratio, ESR, CRP, and procalcitonin) were analyzed as predictors. Concentrations of SP-A and SP-D were measured using a “sandwich” enzyme-linked immunoassay. Results. SP-A concentrations were significantly higher in children with CAP compared to healthy controls (10.6 [5.6; 15.5] ng/mL vs. 5.3 [4.2; 7.5] ng/mL, p < 0.001). Differences in SP-D levels between groups were statistically insignificant (p = 0.132). The logistic regression model for SP-A showed good specificity but low sensitivity. The inclusion of statistically significant variables (neutrophils and ESR) in the model allowed achieving a higher level of sensitivity and specificity, while maintaining the level of confidence, thus improving the discriminatory power and accuracy of the model. Conclusion. Surfactant protein A proved its significance as a diagnostic and prognostic marker of CAP in children, as its level correlated with inflammatory parameters. SP-D showed no diagnostic value, which requires further research. Key words: community-acquired pneumonia, children, diagnostic biomarkers, surfactant protein A, surfactant protein D
- 1 January 2025
- Published by Dynasty Publishing House in Voprosy praktičeskoj pediatrii
- Vol. 20 (2)
Surfactant proteins A and D in the diagnosis of community-acquired pneumonia in children
Community-acquired pneumonia (CAP) remains one of the leading causes of children’s hospitalization, emphasizing the need to find reliable diagnostic biomarkers. Surfactant proteins SP-A and SP-D, which are important components of lung secretion, are considered as potential markers of inflammation in CAP, but their diagnostic significance in pediatric practice remains understudied. Objective. To evaluate the diagnostic value of surfactant proteins A (SP-A) and D (SP-D) in blood for the diagnosis of CAP in children. Patients and methods. This case-control observational study included 88 children. The control group comprised of 29 children without bronchopulmonary pathology, the study group – 59 children with CAP. Clinical parameters (respiratory rate (RR), heart rate (HR), saturation (SpO2), length of hospital stay, levels of surfactant proteins (SP-A and SP-D), inflammatory biomarkers (white blood cell count, neutrophil count, neutrophil-to-lymphocyte ratio, ESR, CRP, and procalcitonin) were analyzed as predictors. Concentrations of SP-A and SP-D were measured using a “sandwich” enzyme-linked immunoassay. Results. SP-A concentrations were significantly higher in children with CAP compared to healthy controls (10.6 [5.6; 15.5] ng/mL vs. 5.3 [4.2; 7.5] ng/mL, p < 0.001). Differences in SP-D levels between groups were statistically insignificant (p = 0.132). The logistic regression model for SP-A showed good specificity but low sensitivity. The inclusion of statistically significant variables (neutrophils and ESR) in the model allowed achieving a higher level of sensitivity and specificity, while maintaining the level of confidence, thus improving the discriminatory power and accuracy of the model. Conclusion. Surfactant protein A proved its significance as a diagnostic and prognostic marker of CAP in children, as its level correlated with inflammatory parameters. SP-D showed no diagnostic value, which requires further research. Key words: community-acquired pneumonia, children, diagnostic biomarkers, surfactant protein A, surfactant protein D
- Open Access
- 15 December 2024
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 4,p. 342-348
Consensus resolution on the antipyretic therapy in ARI in children over 3 years. July 4, 2024, Vladimir; October 5–6, 2024, Kislovodsk
Every year, a seasonal increase in the incidence of respiratory infections is registered in the Russian Federation, primarily among children. It significantly increases the burden on the outpatient pediatric service. It is especially important to optimize the daily practice of pediatricians by developing algorithms and updating treatment protocols, as well as creating and conducting training programs. Fever is a leading symptom in acute respiratory viral infections and one of the most common reasons for seeking help in outpatient pediatric services. Leading experts in the field of therapy of respiratory infections in pediatrics have repeatedly discussed the problems of management of feverish children with acute respiratory infections, routing, personalized choice of therapy regimens at the outpatient stage of medical care. As a result, a number of positions concerning the individual use of antipyretic drugs in children over 3 years of age were agreed upon, “alarming” symptoms requiring immediate assistance/hospitalization were listed, and an algorithm for prescribing antipyretic therapy in children over 3 years of age was agreed upon.
- 15 December 2024
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 4,p. 342-348
Open AccessConsensus resolution on the antipyretic therapy in ARI in children over 3 years. July 4, 2024, Vladimir; October 5–6, 2024, Kislovodsk
Every year, a seasonal increase in the incidence of respiratory infections is registered in the Russian Federation, primarily among children. It significantly increases the burden on the outpatient pediatric service. It is especially important to optimize the daily practice of pediatricians by developing algorithms and updating treatment protocols, as well as creating and conducting training programs. Fever is a leading symptom in acute respiratory viral infections and one of the most common reasons for seeking help in outpatient pediatric services. Leading experts in the field of therapy of respiratory infections in pediatrics have repeatedly discussed the problems of management of feverish children with acute respiratory infections, routing, personalized choice of therapy regimens at the outpatient stage of medical care. As a result, a number of positions concerning the individual use of antipyretic drugs in children over 3 years of age were agreed upon, “alarming” symptoms requiring immediate assistance/hospitalization were listed, and an algorithm for prescribing antipyretic therapy in children over 3 years of age was agreed upon.
- Open Access
- 19 October 2024
- Published by Astrakhan State Medical University in Astrakhan Medical Journal
- Vol. 19 (3) , 87-93
Asthmatic status in pediatric practice in patients with mild bronchial asthma
The main principle of the treatment of bronchial asthma is rational basic therapy, with priority appointment of inhaled glucocorticosteroids. The basis of the effectiveness of treatment is determined by the correct choice of the form of drug delivery, training the patient in inhalation skills and constant monitoring of the correct use of the inhaler. The article demonstrates the clinical observation of the formation of asthmatic status in a child with mild bronchial asthma. The deterioration of the condition and severe exacerbation was caused by insufficient intake of basic therapy funds into the respiratory tract due to improper inhalation techniques due to the patient's lack of skills in using an inhaler. At the same time, the patient was not trained and the necessary control over the correctness of the inhalation technique was not carried out at the outpatient stage.
- 19 October 2024
- Published by Astrakhan State Medical University in Astrakhan Medical Journal
- Vol. 19 (3) , 87-93
Open AccessAsthmatic status in pediatric practice in patients with mild bronchial asthma
The main principle of the treatment of bronchial asthma is rational basic therapy, with priority appointment of inhaled glucocorticosteroids. The basis of the effectiveness of treatment is determined by the correct choice of the form of drug delivery, training the patient in inhalation skills and constant monitoring of the correct use of the inhaler. The article demonstrates the clinical observation of the formation of asthmatic status in a child with mild bronchial asthma. The deterioration of the condition and severe exacerbation was caused by insufficient intake of basic therapy funds into the respiratory tract due to improper inhalation techniques due to the patient's lack of skills in using an inhaler. At the same time, the patient was not trained and the necessary control over the correctness of the inhalation technique was not carried out at the outpatient stage.
- Open Access
- 3 May 2024
- Published by Astrakhan State Medical University in Caspian Journal of Medicine and Pharmacy
- Vol. 5 (1) , 41-47
CLINICAL DIAGNOSTIC VALUE IL-1β LEVELS IN CHILDREN WITH ULCER DISEASE DIDUM AND EROSIVE GASTRODUODENITIS
- 3 May 2024
- Published by Astrakhan State Medical University in Caspian Journal of Medicine and Pharmacy
- Vol. 5 (1) , 41-47
Open AccessCLINICAL DIAGNOSTIC VALUE IL-1β LEVELS IN CHILDREN WITH ULCER DISEASE DIDUM AND EROSIVE GASTRODUODENITIS
- Open Access
- 12 March 2024
- Published by Consilium Medicum in Consilium Medicum
- Vol. 25 (12) , 834-837
Microbiota of the upper respiratory tract in children with chronic adenoiditis
Background. Routine application of the GC-MS method to assess the URT microbiota can potentially improve the efficacy and safety of treatment for chronic respiratory diseases. Aim. To perform a comparative analysis of the microbiota from the surface of the pharyngeal tonsil, from the deep parts of the nose, and saliva in children with chronic adenoiditis. Materials and methods. The study included 90 patients with chronic adenoiditis (CA) and/or pharyngeal tonsil hypertrophy (PTH). All study participants had swabs taken from the surface of the pharyngeal tonsil, from the deep parts of the nasal cavity, and saliva as a biological fluid of the oral cavity. Microorganisms were identified by specific fatty acids using GC-MS to assess the composition of the microbial community on the surface of the pharyngeal tonsil. Results. The study showed that the microbiota of the nasopharynx is identical in its qualitative composition to microorganisms from the deep parts of the nose. However, according to the results of the analysis of microbial markers of saliva, the oral microbiota showed significant differences in the quantitative and qualitative composition of microorganisms compared with the nasopharyngeal microbiota. Conclusion. The introduction of the GC-MS method for assessing the URT microbiota enables its monitoring in clinical practice for the treatment of chronic respiratory system diseases without disturbing the ecology of the mucous membranes and the whole body.
- 12 March 2024
- Published by Consilium Medicum in Consilium Medicum
- Vol. 25 (12) , 834-837
Open AccessMicrobiota of the upper respiratory tract in children with chronic adenoiditis
Background. Routine application of the GC-MS method to assess the URT microbiota can potentially improve the efficacy and safety of treatment for chronic respiratory diseases. Aim. To perform a comparative analysis of the microbiota from the surface of the pharyngeal tonsil, from the deep parts of the nose, and saliva in children with chronic adenoiditis. Materials and methods. The study included 90 patients with chronic adenoiditis (CA) and/or pharyngeal tonsil hypertrophy (PTH). All study participants had swabs taken from the surface of the pharyngeal tonsil, from the deep parts of the nasal cavity, and saliva as a biological fluid of the oral cavity. Microorganisms were identified by specific fatty acids using GC-MS to assess the composition of the microbial community on the surface of the pharyngeal tonsil. Results. The study showed that the microbiota of the nasopharynx is identical in its qualitative composition to microorganisms from the deep parts of the nose. However, according to the results of the analysis of microbial markers of saliva, the oral microbiota showed significant differences in the quantitative and qualitative composition of microorganisms compared with the nasopharyngeal microbiota. Conclusion. The introduction of the GC-MS method for assessing the URT microbiota enables its monitoring in clinical practice for the treatment of chronic respiratory system diseases without disturbing the ecology of the mucous membranes and the whole body.
- 1 January 2024
- Published by Cifra Ltd - Russian Agency for Digital Standardization (RADS)
Витамин D: от простого к сложному
Монография посвящена актуальной для педиатрии проблеме недостаточности и дефицита витамина D, данная тема рассматривается авторами для совершенстования оказания медицинской помощи детям по профилю «Педиатрия». Монография освещает современные представления о механизмах формирования недостаточности витамина D, профилактических стратегиях у здоровых детей и терапевтических подходах у пациентов с различными заболеваниями. Подробно описана история открытия и изучения витамина D, представлены современные данные о механизмах метаболизма и его генетического контроля. Состояние обеспеченности витамином D рассматривается авторами через призму комплексного анализа эпигенетических факторов, как экзогенных (сезон года), так и эндогенных (возраст, пол, заболевания). Учитывая роль витамина D как фактора, модулирующего процесс воспаления, в монографии проведен анализ обеспеченности им в крупных когортах детей и взрослых различного возраста на территории РФ и за рубежом, в связи с негативными долгосрочными эффектами его низкого содержания. Приведены результаты исследований по уточнению профилактических доз витамина D для практически здоровых, а также детей с хроническими заболеваниями, поскольку без таргетных профилактических стратегий шансы на успех в нормализации уровня витамина D у детей практически минимальны. При подготовке данной монографии обобщены достижения мировой науки, а также собственный клинический опыт всех авторов. Авторский коллектив надеется, что монография будет полезна практикующим врачам различных специальностей, научным сотрудникам, а также студентам медицинских вузов, всем тем, от кого зависит, насколько успешной будет борьба за здоровье и улучшение качества жизни детей.
- 1 January 2024
- Published by Cifra Ltd - Russian Agency for Digital Standardization (RADS)
Витамин D: от простого к сложному
Монография посвящена актуальной для педиатрии проблеме недостаточности и дефицита витамина D, данная тема рассматривается авторами для совершенстования оказания медицинской помощи детям по профилю «Педиатрия». Монография освещает современные представления о механизмах формирования недостаточности витамина D, профилактических стратегиях у здоровых детей и терапевтических подходах у пациентов с различными заболеваниями. Подробно описана история открытия и изучения витамина D, представлены современные данные о механизмах метаболизма и его генетического контроля. Состояние обеспеченности витамином D рассматривается авторами через призму комплексного анализа эпигенетических факторов, как экзогенных (сезон года), так и эндогенных (возраст, пол, заболевания). Учитывая роль витамина D как фактора, модулирующего процесс воспаления, в монографии проведен анализ обеспеченности им в крупных когортах детей и взрослых различного возраста на территории РФ и за рубежом, в связи с негативными долгосрочными эффектами его низкого содержания. Приведены результаты исследований по уточнению профилактических доз витамина D для практически здоровых, а также детей с хроническими заболеваниями, поскольку без таргетных профилактических стратегий шансы на успех в нормализации уровня витамина D у детей практически минимальны. При подготовке данной монографии обобщены достижения мировой науки, а также собственный клинический опыт всех авторов. Авторский коллектив надеется, что монография будет полезна практикующим врачам различных специальностей, научным сотрудникам, а также студентам медицинских вузов, всем тем, от кого зависит, насколько успешной будет борьба за здоровье и улучшение качества жизни детей.